Ever since graduating from business school in 2006, one of my favorite ways to learn is through case studies. And there’s no better case study for understanding the IPO quiet period than Anthropic’s upcoming IPO.
Anthropic is expected to publicly file its IPO prospectus after Labor Day, with a listing as soon as late September or early October. The Information reported it on August 27 and Reuters picked it up the same day, although nothing is certain.
Between now and then, you’re going to read a lot about Anthropic. Almost none of it will come from Anthropic.
That’s the quiet period doing its job, and most investors misunderstand what it does. They think the whole world goes silent. It doesn’t. The company goes silent. Everybody else keeps talking, which creates one of the strangest information environments in all of investing.
I spent 13 years in equities at a couple of investment banks, from 1999 to 2012. During that stretch I worked on well over 100 IPOs. I sat with management teams through roadshow lunches, introduced them to my clients’ offices, provide demand feedback to the syndicate desk, and fought for allocation for the accounts that deserved it. And sometimes for the ones that just yelled loudest.
So I’ve watched this process from the inside, repeatedly, through the dot-com bubble and the 2008 crash. Here’s how it actually works, and what it means if you’re trying to build exposure to Anthropic, or any private company, before it lists.
A disclaimer. I’m not a securities lawyer, and I’ve been out of the industry since 2012. I’m just a guy who kickstarted the modern-day FIRE movement in 2009 when I started writing about my plan to escape Corporate America. I own roughly $435,000 of Anthropic at a $965 billion valuation through traditional and public venture capital. I’m trying to build more Anthropic exposure through VCX at the lowest price possible before the roadshow begins. So read accordingly.
The Quiet Period Is Not One Period
First, clear up a naming problem. People use quiet period to mean two completely different things.
For an already-public company, it refers to the self-imposed blackout before earnings, when management stops talking to investors. That is convention, not law.
For a company going public, it means something else entirely. It is a set of legal restrictions under the Securities Act of 1933 that govern what an issuer may say while it is in registration. That is the one we care about, and it comes in three phases that get progressively looser, not tighter.
Phase one, pre-filing. From the moment a company decides to go public until it publicly files, Section 5(c) prohibits offers entirely. Written, oral, doesn’t matter. And offer is defined so broadly that publicity designed to condition the market counts. This is the phase lawyers call gun-jumping, and it is the most restrictive of the three.
Phase two, the waiting period. Once the registration statement is publicly filed, the company gains latitude. Oral offers become permissible. The preliminary prospectus can circulate. This is when the roadshow happens.
Phase three, post-effective. Shares price and trade. For a company listing on a national exchange, a 25-day prospectus delivery requirement follows, after which normal disclosure rules take over.
Notice the direction of travel. The gag loosens after the public filing, not before. Which brings us to where Anthropic is sitting right now.
Anthropic Is In The Tightest Phase Today
Anthropic submitted a confidential draft S-1 on June 1, 2026. Confidential means the SEC reviews it privately. The public has seen nothing. An EDGAR check on August 31 turned up no S-1 or S-1/A.
So technically Anthropic has not filed a registration statement at all. It is in phase one. No offers, written or oral.
There is a second squeeze most people miss. A rule known as 163A gives companies a safe harbor for communications made more than 30 days before filing, as long as they don’t reference the offering. With a public filing expected right after September 7, Anthropic is now inside that 30-day window and has lost the safe harbor.
In other words, their lawyers got stricter this month, not looser.
The behavioral tells are all there if you know what to look for.
When Anthropic announced the confidential filing on June 1, the Anthropic’s blog post explicitly cited Rule 135. That is the narrow safe harbor letting a company say an offering exists without that statement legally becoming an offer. Companies name-check Rule 135 when counsel is driving the car.
When The Information broke the Labor Day timeline, the sourcing was people familiar with the process. Reuters noted Anthropic did not respond to a request for comment. Silence on the record while bankers and insiders talk is the signature of a company in registration.
And when Anthropic disclosed on August 17 that its annualized run rate had passed $65 billion, up from $47 billion in mid-May, look at what the disclosure did not include. No valuation commentary, projection, or mention of the offering. Rules 168 and 169 permit ordinary-course factual business information, and that is precisely, carefully, all it was.
Here Is The Part Investors May Get Wrong
The restrictions bind the issuer and its underwriters. That’s it.
Bloomberg can report. CNBC can speculate. Analysts at firms not on the deal can publish price targets. Prediction markets can quote odds. I can write this post. None of us are in registration, so none of us are restricted.
This produces an information environment that is genuinely bizarre. The single entity that knows the most about Anthropic is the one legally prevented from telling you anything, while thousands of people who know considerably less face no constraint whatsoever.
Every valuation number floating around right now, the $1.5 trillion, the $2 trillion, the secondary marks above $1.2 trillion, comes from reporters, bankers speaking off the record, or people like me doing arithmetic. Not from the company.
So please discount everything you read, including information from me. The only people who know all the details are company management and its bankers.
The 10-Day Research Blackout Nobody Talks About
There is a second quiet period stacked on top of the first, and it is the one I paid the most attention to in my old job.
Under FINRA rules, a firm that acted as manager or co-manager on an IPO cannot publish research on that company for 10 calendar days after it starts trading. So Goldman Sachs, Morgan Stanley and JPMorgan, the three banks leading this deal, will be silent on Anthropic through the listing and for a week and a half after. There will be many more book runners given the IPO size is expected to surpass SpaceX’s.
Then, on roughly day 11, all three initiate coverage at once.
I watched this happen more than a hundred times. It is not subtle. A stock trades for two weeks on retail flow, momentum and whatever the non-underwriter shops publish. Then the bulge bracket price targets land in a cluster, usually generous, and the stock gets a second look from institutions who were waiting for the sell-side blessing.
If Anthropic lists in early October, mark roughly mid-October on your calendar. That is the second event, and it is separate from the listing itself.
Why Any Of This Matters For VCX
I own Anthropic exposure two ways. Through traditional venture funds where I’m a limited partner, and through Fundrise’s Innovation Fund, VCX, where Anthropic is about 22% of net assets and roughly 29% of the actual startup portfolio.
I’m about $425,000 into a $500,000 Anthropic position and still building. So the quiet period is not an academic topic for me. It’s a pricing mechanism. To build another $75,000 position in Anthropic requires me to buy about $340,000 more of VCX, ideally, at the lowest price possible before the IPO roadshow begins.
Think about what the gag actually suppresses. It stops the company from hyping its own stock. No CEO on CNBC talking about the total addressable market. No investor deck circulating. Nothing from management blessing valuation or forecasts.
For someone still accumulating, that is useful. The most powerful marketing engine in this deal, Anthropic itself, is legally muzzled for the exact stretch I’m trying to buy in. Whatever enthusiasm exists right now is running without the company’s help.
Then the prospectus lands, and the vacuum fills all at once.
What The S-1 Will Actually Do
The public S-1 is not just a legal formality. It’s the first verified look at a company everyone has been guessing about for a year.
Audited financials. Gross margin, which tells you what it costs Anthropic to serve a dollar of inference and which absolutely nobody outside the company knows today. Customer concentration. The full cap table and share count. Risk factors, written by lawyers who are required to enumerate everything that could go wrong.
That document will be covered for days. It’s the moment Anthropic is growing fast becomes a set of numbers retail investors can actually price against. There will certainly be disclaimer languages and negative shocks, that the media will run with as well.
And here is the thing about the mechanics that I think is underappreciated. Retail will get only a tiny allocation in a hot IPO, which Anthropic’s will be. That is not a conspiracy, it’s just how the book works. I spent years fighting for allocation on behalf of institutional clients managing billions, and even they got cut back on hot deals. An individual investor with a brokerage account is not getting a meaningful piece of the largest IPO in history.
Which is exactly why vehicles that already own the shares matter. If you can’t get in the front door, you buy something that walked in years ago.
What I’m Doing
My plan is unromantic. Keep accumulating VCX while the company is muzzled and the last officially reported NAV is a stale June figure. Hold through the S-1 and the listing. My target is $50 in 2027.
The risk is obvious. The quiet period could just as easily be masking bad news as good. Nobody outside Anthropic has seen an audited income statement. If gross margins come in worse than the market assumes, or customer concentration is uglier than expected, the S-1 becomes the catalyst in the other direction. Every argument I’ve made about the information vacuum cuts both ways.
I’m also aware that I’m talking my book here. I own this. Discount accordingly and do your own work.
But after watching a hundred-plus companies go through this exact sequence, the pattern I keep coming back to is that the quiet period is not a pause in the story. It’s the compression before the release. The information doesn’t disappear. It piles up behind a legal dam and then arrives all at once, in a document, on a date you can roughly predict.
As an AI maximalist and Anthropic shareholder, I’m looking forward to what comes next. Warts and all, though I’m betting on beauty.
I’ve written before about being willing to take more risk to avoid being average. If I’m wrong, so be it. That’s the price of admission for anyone hoping to do better than the index.
Reader Questions
Have you ever tried to get IPO allocation as an individual investor? How did that go? And if you’re building pre-IPO exposure to Anthropic or OpenAI, what route are you using? Curious whether anybody has found something better than the closed-end fund workaround.
Disclosure: Fundrise is a long-time sponsor of Financial Samurai and I am an investor in Fundrise funds, including the Innovation Fund (VCX). I am also a limited partner in multiple venture funds with Anthropic exposure. Nothing here is investment or legal advice. Securities regulations are complex and fact-specific, and I am neither a lawyer nor your advisor.
Want every new post the moment it publishes, ad-free for the first few hours? Sign up at here.
Read the full article here
